RxDoctor Payments Data

Emily Fechner, PA

Physician Assistant · Morton Grove, ILNPI 1669839304

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.4% of the total across 831 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,446in general payments, 2019–2025

Across 831 payments — averaging $22.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$3K
  • Johnson & Johnson$1K
  • AstraZeneca$871
  • Pfizer$861
  • E.r. Squibb & Sons, L.L.C.$764
  • Amgen$753
  • plus $10K from 54 others

What the payments were for

  • Food & beverage$16,86091%
  • Education$3062%
  • Other$1,2807%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis134$3,217
Johnson & Johnson(2 entities)61$1,322
AstraZeneca(2 entities)32$871
Pfizer51$861
E.r. Squibb & Sons, L.L.C.37$764
Amgen31$753
Merck33$718
Incyte Corporation22$657
Takeda Pharmaceuticals U.S.A., Inc.24$614
AbbVie38$613
Dendreon Pharmaceuticals LLC23$538
Genentech USA, Inc.31$531
Lilly USA, LLC26$450
Seagen Inc.20$436
Bristol Myers Squibb19$434
Sanofi19$427
Regeneron Healthcare Solutions, Inc.14$369
Daiichi Sankyo Inc.19$328
Tersera Therapeutics LLC16$302
Beigene USA, Inc.10$291
Adaptive Biotechnologies Corporation11$261
Pharmacyclics LLC, An Abbvie Company11$244
Jazz Pharmaceuticals Inc.9$235
Gilead(2 entities)8$184
Servier Pharmaceuticals LLC8$174
Blue Earth Diagnostics7$161
Mirati Therapeutics, Inc.6$153
GSK7$149
Pharmacosmos Therapeutics Inc.6$143
EMD Serono, Inc.6$134
Bayer6$130
Blueprint Medicines Corporation4$111
Sobi, Inc5$110
Astellas Pharma US Inc5$107
Morphosys, US Inc.5$107
Agios Pharmaceuticals, Inc.3$106
Eisai Inc.4$100
Deciphera Pharmaceuticals Inc.4$98
Karyopharm Therapeutics Inc.3$81
G1 Therapeutics, Inc.4$75
Alnylam Pharmaceuticals Inc.3$69
Pharmaessentia USA Corporation3$67
EUSA Pharma (US) LLC3$60
Geron Corporation2$58
Novocure Inc.3$58
AVEO Pharmaceuticals, Inc.2$57
Array Biopharma Inc2$53
ADC Therapeutics America, Inc.2$50
CTI Biopharma Corp.2$48
Novo Nordisk2$47
Intera Oncology, Inc1$43
Tempus AI, Inc2$40
AMAG Pharmaceuticals, Inc.2$38
Acrotech Biopharma Inc.2$36
Boehringer Ingelheim1$31
Menarini Silicon Biosystems, Inc.2$30
Stemline Therapeutics Inc.1$28
Kyowa Kirin, Inc.1$24
Taiho Oncology, Inc.1$24
Exelixis Inc.1$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,446 in reported general payments places this provider in the 95th percentile of 3,912 physician assistant providers in Illinois.

See all physician assistant providers in Illinois

Medicare billing

Part B allowed, 2024
$578,750
Medicare patients
182
Services billed
26,769

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban14$7,700
Ondansetron OdtOndansetron19$526
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen21$378
Prochlorperazine Maleate18$315
Warfarin Sodium15$120
Alprazolam19$97
Tramadol Hcl16$83

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$861$7,70014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,912 physician assistant providers in Illinois.

Other physician assistant in Morton Grove

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →